Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals

被引：0
|
作者：
Maryam H. Alrashid
Ahmad Al-Serri
Salem H. Alshemmari
Philip Koshi
Suzanne A. Al-Bustan
机构：
[1] Kuwait University,Department of Biological Sciences, Faculty of Science
[2] Kuwait University,Department of Pathology, Faculty of Medicine
[3] Kuwait University,Department of Medicine, Faculty of Medicine
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
Warfarin; International Normalization Ratio; Single Nucleotide Polymorphism; Warfarin Dose; Warfarin Dose Requirement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：183 / 190
页数：7
相关论文
共 50 条
  • [21] Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes
    Wen, Ming-Shien
    Lee, M. T. Michael
    Chen, Jin-Jer
    Chuang, Hui-Ping
    Lu, Liang-Suei
    Chen, Chien-Hsiun
    Lee, Tsong-Hai
    Kuo, Chi-Tai
    Sun, Feng-Mei
    Chang, Yeu-Jhy
    Kuan, Pei-Liang
    Chen, Ying-Fu
    Charng, Min-Ji
    Ray, Chin-Ying
    Wu, Jer-Yuan
    Chen, Yuan-Tsong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 50 - 50
  • [22] Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes
    Wen, M-S
    Lee, M. T. M.
    Chen, J-J
    Chuang, H-P
    Lu, L-S
    Chen, C-H
    Lee, T-H
    Kuo, C-T
    Sun, F-M
    Chang, Y-J
    Kuan, P-L
    Chen, Y-F
    Charng, M-J
    Ray, C-Y
    Wu, J-Y
    Chen, Y-T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (01) : 83 - 89
  • [23] CYP2C9 and VKORC1 Genetic Polymorphisms in Patients Receiving Warfarin - Improving Safety and Therapeutic Treatment
    Ditta, L.
    Jain, N.
    Schult, G.
    Mansi, I.
    Mills, G.
    Nordberg, M. Lowery
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 567 - 567
  • [24] Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
    Fung, Erik
    Patsopoulos, Nikolaos A.
    Belknap, Steven M.
    O'Rourke, Daniel J.
    Robb, John F.
    Anderson, Jeffrey L.
    Shworak, Nicholas W.
    Moore, Jason H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (08): : 893 - 904
  • [25] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [26] The accuracy of warfarin dosage based on VKORC1 and CYP2C9 phenotypes in a Chinese population
    Wijaya, Agustinus
    Bo, Jiang T.
    Jun, He
    Ping, Jiang W.
    Bin, Jiang
    Jie, Chen H.
    Wen, Yang B.
    Zhu, Xu M.
    Cheng, Qiu Q.
    MEDICAL JOURNAL OF INDONESIA, 2012, 21 (02) : 108 - 112
  • [27] The influence of VKORC1 and CYP2C9 genetic polymorphisms on early INR control in patients commencing warfarin
    Lund, K. A.
    Gaffney, D.
    Etherington, A. M.
    Fyfe, A. J.
    Tansey, P. J.
    Spooner, R. J.
    Tait, R. C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 44 - 44
  • [28] Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People
    Esmerian, Maria O.
    Mitri, Zahi
    Habbal, Mohammad-Zuheir
    Geryess, Eddy
    Zaatari, Ghazi
    Alam, Samir
    Skouri, Hadi N.
    Mahfouz, Rami A.
    Taher, Ali
    Zgheib, Nathalie K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (10): : 1418 - 1428
  • [29] Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population
    Chowdhury, Zahid Sadek
    Shahjin, Farah
    Akter, Farhana
    Ahmed, Maizbha Uddin
    Islam, Mohammad Safiqul
    Bin Sayeed, Muhammad Shandaat
    Islam, Reazul
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 30 (02) : 341 - 346
  • [30] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    G. Oner Ozgon
    T. Y. Langaee
    H. Feng
    N. Buyru
    T. Ulutin
    A. C. Hatemi
    A. Siva
    S. Saip
    J. A. Johnson
    European Journal of Clinical Pharmacology, 2008, 64 : 889 - 894
12345